+
+
Stay Informed
SURGICAL VALVE SOLUTIONS

EPIC™ MITRAL AND AORTIC STENTED TISSUE VALVES CLINICAL DATA

The Epic Platform has been proven over time and defined by strong hemodynamics, intuitive implantability,  and a future-forward design that gives you and your patients more choices when it comes to preserving long-term treatment paths.

SURGICAL VALVE SOLUTIONS

EPIC™ MITRAL AND AORTIC STENTED TISSUE VALVES CLINICAL DATA

The Epic Platform has been proven over time and defined by strong hemodynamics, intuitive implantability,  and a future-forward design that gives you and your patients more choices when it comes to preserving long-term treatment paths.

DURABILITY THAT WITHSTANDS
THE LONG-TERM TEST OF TIME

At 10 Years

93.8%*

Freedom from SVD,
all patient ages (Epic™ Mitral VALVE)1

96.3%*

Freedom from SVD,
all patient ages (Epic™ Aortic VALVE)2

SVD: structural valve deterioration.
*From stand-alone aortic or mitral valve replacements.
 

THE EPIC PLATFORM HAS DEMONSTRATED EXCELLENT DURABILITY IN YOUNGER PATIENTS

The Epic™ Mitral valve experience from Rennes shows excellent performance in younger patients, with a 10-year freedom from SVD of 87.7% for the age ≤ 59 subgroup.3

 

87.7%

EPIC MITRAL VALVE
Freedom from SVD,
at 10 YEARS3

EPIC SUPRA VALVE DELIVERS EXCEPTIONAL DURABILITY AND PERFORMANCE

  • Optimal leaflet design minimizes regurgitation
  • Pericardial shield reduces abrasion by creating tissue-to-tissue interface
  • Epic valve 10-year durability data show outstanding aortic freedom from SVD2 

96.3%

EPIC AORTIC VALVE
Freedom from SVD,
at 10 YEARS2

STRONG IN VIVO HEMODYNAMICS

Epic - strong in vivo hemodynamics

*NOTE: For references 4-8, data not from head to head studies. Data differences depicted between these trials may not be directly comparable, statistically significant, or clinically meaningful due to differences in trial protocols, endpoints, and/or patient populations. Data provided for informational purposes only.
†Pressure Gradients approximated through Epic Aortic SSED data matched with stent size equivalencies for the Epic Supra. Per Abbott Internal engineering specifications, a 19 mm Epic Supra has the same stent size as a 21 mm Epic Aortic and this relationship continues across all Epic Supra valve sizes.
‡Indicates a third-party trademark, which is property of its respective owner.

MAT-2201679 v1.0 | Item approved for Global OUS use only.

References
  1. Lehmann S, Jawad K, Meyer A, et al. Long-term follow-up after porcine xenograft mitral valve replacement. Presented at: 2017 American Association For Thoracic Surgery Mitral Conclave. April 27-28, 2017; New York, NY, USA.
  2. Lehmann, S, Merk DR, Etz CD, et al. Porcine xenograft for aortic, mitral and double valve replacement: long-term results of 2544 consecutive patients. Eur J Cardiothorac Surg. 2016;49:1150-1156.
  3. Anselmi A, Aymami M, Tomasi J et al. Durability of mitral valve replacement with a 3rd generation bioprosthesis. Ann Thorac Surg. 2021. doi: doi. org/10.1016/j.athoracsur.2021.03.097.
  4. Biocor Instructions for Use.
  5. Maitland A, Hirsch GA, and Pascoe EA. Hemodynamic performance of the St. Jude Medical Epic Supra Aortic Stented Valve. J Heart Valve Dis, 2011; 20:327-331.
  6. Mosaic Instructions for Use.
  7. Resilia Instructions for Use.
  8. Magna Ease Instructions for Use.
Abbott Logo

Making an everlasting
impact On human health
for 130 years

Follow Abbott

Copyright © 2023 Abbott, 3200 Lakeside Dr, Santa Clara, 95054, U.S.A.
Caution: These products are intended for use by or under the direction of a physician. Prior to use, reference the Instructions for Use, inside the product carton (when available) or at eifu.abbottvascular.com or at medical.abbott/manuals for more detailed information on Indications, Contraindications, Warnings, Precautions and Adverse Events.
Illustrations are artist’s representations only and should not be considered as engineering drawings or photographs. Photos on file at Abbott.
Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

MAT-2000631 v14.0 | Item approved for OUS use only.

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

U.S. Health Care Professionals International Health Care Professionals

YOU ARE ABOUT TO LEAVE
www.structural­heart.abbott

You are now leaving www.structuralheart.abbott. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

OkCancel